Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Orphagen Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Orphagen Pharmaceuticals (United States)

San Diego, Californiacompany

10

Works

918

Citations

20

h-index

Top Research Topics

Psoriasis: Treatment and Pathogenesis Cytokine Signaling Pathways and Interactions NF-κB Signaling Pathways

Top Researchers

Xiaolin Li Shandong University of Traditional Chinese Medicine

234 works7,927 citationsh-index: 46

Recent Research

Cost-effectiveness of vasopressin in the treatment of septic shock: insights from a European societal perspective

Evelyn Walter,Federico Ghinelli,et al.

20260 citations

Adrenal and Paraganglionic Tumors

Hormonal Regulation and Hypertension

T-cell and B-cell Immunology

Sepsis Diagnosis and Treatment

Immune Response and Inflammation

Immunotherapy and Immune Responses

Cancer, Hypoxia, and Metabolism

Immune Cell Function and Interaction

Trauma, Hemostasis, Coagulopathy, Resuscitation

Xiaolin Li Guangzhou University of Chinese Medicine

445 works7,201 citationsh-index: 44

Paul D. Crowe Orphagen Pharmaceuticals (United States)

73 works5,120 citationsh-index: 32

Hai‐Yan Tao China University of Geosciences

162 works4,005 citationsh-index: 43

Erin K. Bradley Rady Children's Hospital-San Diego

59 works2,244 citationsh-index: 22

Robert E. Babine Orphagen Pharmaceuticals (United States)

58 works1,922 citationsh-index: 18

A Concise and Modular Approach to Generate Novel RORγ Agonists

Setsuo Fukuda,Taku Ikenogami,et al.

20251 citations

Pharmacological Properties of JTE-151; A Novel Orally Available RORγ Antagonist That Suppresses Th17 Cell-Related Responses <i>in Vitro</i> and <i>in Vivo</i>

Kojo Arita,Hai‐Yan Tao,et al.

20244 citations

Discovery and SAR of JTE-151: A Novel RORγ Inhibitor for Clinical Development

Takaki Maeba,Kazuyuki Hirata,et al.

20246 citations

A Novel Steroidogenic Factor-1 Antagonist, OR-449, as a Targeted Therapy for Adrenocortical Cancer

Paul Crowe,Ray Fox,et al.

20210 citations

SUN-LB23 Translational Feasibility of Steroidogenic Factor-1 Antagonists as a Novel Targeted Therapy for Adrenocortical Cancer

Paul Crowe,Hai‐Yan Tao,et al.

20200 citations